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Abstract 
 
Introduction 
One method to overcome the problem of lung tumour movement in patients treated with 
radiotherapy is to restrict tumour motion with an Active Breathing Control (ABC) device.  This 
study evaluated the feasibility of using ABC in patients receiving radical radiotherapy for non 
small cell lung cancer.  
 
Method 
18 patients, median (range)  age of 66 (44-82)years,  were consented for the study. A training 
session was conducted to establish the patient’s breath hold level and breath hold time. Three 
planning scans were acquired using the ABC device. Reproducibility of breath hold was assessed 
by comparing lung volumes measured from the planning scans and the volume recorded by ABC. 
Patients were treated with a 3-field coplanar beam arrangement and treatment time (patient on 
and off the bed) and number of breath holds recorded.  The tolerability of the device was 
assessed by weekly questionnaire. Quality assurance was performed on the two ABC devices 
used.  
 
Results 
17/18 patients completed 32 fractions of radiotherapy using ABC. All patients tolerated a 
maximum breath hold time >15secs. The mean (SD) patient training time was 13.8 (4.8) min and 
no patient found the ABC very uncomfortable.   6-13 breath holds of 10-14 secs were required 
per session. The mean treatment time was 15.8 mins (5.8 mins). The breath hold volumes were 
reproducible during treatment and also between the two ABC devices. 
 
Conclusion  
The use of ABC in patients receiving radical radiotherapy for NSCLC is feasible. It was not 
possible to predict a patient’s ability to breath hold. A minimum tolerated breath hold time of 15 
seconds is recommended prior to commencing treatment.  
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Introduction  
 
Lung tumour movement is one of the major challenges in radiotherapy. A patient's breathing 
pattern varies from day to day and can vary during an individual radiotherapy fraction. The range 
of motion has been found to be as much as 12mm +/- 6mm in lower lobe tumours  [1]. As a 
consequence planning target volume (PTV) margins in the region of 1.5-2cm are used when 
treating patients with radical radiotherapy. There are varying technical approaches being 
investigated to compensate for tumour motion and hence reduce margins. These include tracking 
the tumour [2], gating the  treatment delivery to part of the respiratory cycle [3,4] and using  4d CT 
to determine the tumour mean position and create an internal target volume [5]. An alternative 
approach is to reduce the motion by using either a  voluntary breath hold [6] or an assisted breath 
hold with an active breathing control device (Active Breathing Co ordinator™, ABC) [6,7].  The 
potential of using ABC to reduce motion has been explored by comparing CT scans with and 
without ABC [8,9,7]. ABC has been used for treatment of Hodgkin’s disease [10] and  breast 
cancer [11] and was well tolerated. It has been speculated that the use of ABC during radical 
radiotherapy for lung cancer would be too demanding for patients [12,13,14]. However we have 
found in a previous study that lung cancer patients can maintain an average breath hold time of 
20 seconds [15]. Although there are studies that report the treatment of lung cancer patients with 
ABC, reproducibility rather than feasibility was the focus [16,17].  In this study we test the 
feasibility of treating NSCLC patients with radical radiotherapy using ABC. The tolerability of the 
ABC is assessed and the procedure for treatment and time taken is presented. A quality 
assurance procedure for the ABC is also described. 
 
Methods  
 
The study protocol was approved by the local Committee for Clinical Research (CCR) and Local 
Research Ethics Committee (REC). Eighteen patients referred for radical radiotherapy for non 
small cell lung cancer (NSCLC) were consented for treatment using ABC. The mean (SD) age of 
the 18 patients consented was 68(10) years. 17 patients were performance status (PS)  0 or 1 
and one patient was PS 2. FEV1 (range 1.36-3.03) was available for 9 patients. Five tumours 
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were positioned in the lower lobe, 8 in the upper lobe and 5 in the middle lobe (Table1)... 13 
patients had received neo adjuvant chemotherapy (2-4 cycles of platinum based doublet).  
 The ABC device enables patients to maintain a breath hold at a predetermined volume and 
length of time. It consists of a mouthpiece connected to a turbine-type flow meter and a balloon 
valve which is controlled via a signal from a laptop computer outside the treatment room.  The 
patient also has the ability to release the valve by depressing a handheld switch.  
 
Patient training 
Patients were trained immediately prior to the planning CT scan.  Initially they were shown how to 
correctly position the mouthpiece between their teeth and lips and the importance of maintaining 
a good seal around the mouthpiece with their lips was emphasised [18]. Subsequently they 
assumed the treatment position on a lung board developed in-house. They were asked to breathe 
freely through the mouthpiece and with the nose clip attached until they felt comfortable i.e when 
the breathing trace on the ABC screen was regular. They were then asked to perform repeated 
deep breaths with gentle breaths in between and the maximum inspiratory volume (MIV) was 
recorded. The breath hold volume for treatment (threshold level) was initially set at 70% of the 
MIV and a 5 second breath hold time was entered. Next they were asked to take a deep breath 
and assisted breath hold commenced when the breathing trace crossed the threshold volume 
level. The remaining breath hold time in seconds were counted down via the room microphone by 
the radiographer controlling the device whilst another radiographer remained with the patient to 
reassure and check comfort.  The breath holds were increased by 5 second intervals only when 
the patient was comfortable. The maximum breath hold time and the threshold level were saved 
in the patient’s file in the ABC programme and the time from entering the room to reaching the 
maximum breath hold time recorded.  
 
CT planning 
When maximum breath hold time was reached a contrast scan in free breathing (FB), without the 
ABC device, was acquired (Philips Brilliance CT Big Bore, Philips Medical Systems UK) using 
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2mm slice thickness.  The tattoo positions were marked in free breathing for patient alignment 
prior to treatment and the scan completed in breath hold. To determine the breath hold time 
necessary for the scan a surview was acquired with ABC. An extra 5 seconds was added onto 
the scan time indicated from the scanner to determine the total breath hold time required for the 
scan to be captured in a single breath hold. If this was not possible then a split scan was 
performed. A fast protocol was used by decreasing the rotation time from 0.75 secs to 0.5 secs 
and increasing the pitch from 0.3 to 0.7. Although the increased pitch may reduce the resolution 
this was compensated by eliminating blurring effect due to breathing. Intrafraction reproducibility 
was assessed by immediately repeating the planning scan with 2 further breath holds. 
A 3-field coplanar conformal plan treating patients to a dose of 64Gy in 32 fractions was produced 
for each scan using Pinnacle3 (Philips, Reigate, UK). GTV volumes ranged between 6.4cm3 – 
96.3cm3 (Table 1). 
The simulator was used to verify the isocentre in breath hold using digitally reconstructed 
radiographs (DRRs) imported into Omnipro (IBA, Schwarzenbruck, Germany). This also 
familiarised the patients with the ABC procedure before the start of treatment.    
 
Treatment delivery and verification 
Patients were treated on Elekta linear accelerators (Elekta Oncology Systems Ltd Crawley, West 
Sussex, England) with iview GT electronic portal imaging (EPI) system.  The patient was aligned 
to the tattoos in free breathing. The isocentre from the ABC plan was set in the anterior-posterior 
(AP) direction using the couch height, correcting for couch sag. In the right-left (RL) and superior-
inferior (SI) directions the isocentre was initially set to the anterior tattoo in breath hold. The 
couch position was noted and the required distance to the planned isocentre moved using the 
couch read out hence allowing the patient to breathe freely.  
Audio instructions were given from outside the room. The patient was prompted at the peak of a 
breathing cycle to ‘breathe gently and then when you are ready take a deep breath in’. The linac 
was switched on at the trough of the breath prior to the hold to compensate for the ~3-4 sec time 
delay from switch on to radiation ‘on’ (Fig 1). The maximum breath hold time was used and a 
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radiographer counted the seconds down using the audio system. The linac and ABC interface 
were not connected which meant if either the treatment beam or the breath hold had completed 
the duty cycle the other could be individually interrupted and manually restored.    
Orthogonal EPI were taken to evaluate any treatment set-up displacement. A no action level 
(NAL) protocol was used; on the first three fractions EPI ‘s were averaged to calculate the 
systematic errors and this was corrected for on fraction four [19]. EPIs were repeated weekly and 
a tolerance of 6 mm used for bony anatomy displacement.  The set up displacement, with and 
without correction applied  was used to calculate the systematic error (∑) of the group, the 
standard deviation (SD) of the distribution of the average set-up displacements per patient and 
the random error (σ) of the group, the SD of the patients’ set-up displacements averaged over the 
patient group. During treatment the total treatment time (patient on and off the bed) and number 
and length of breath holds required were recorded. Patients were asked to fill in a questionnaire 
weekly and rate how uncomfortable they found the device, choosing from; Not at all, A little, Quite 
a bit, or Very much. There was also free text space for comments.  
To assess interfraction reproducibility of tumour position during radiotherapy two further CT scans 
using the ABC device were acquired in the middle (ABCmid) and at the end of the treatment 
schedule (ABCend) for the first 13 patients.  
 
Staff training 
Training sessions were conducted with the staff prior to use. This included an overview of the 
system and practising activating the ABC device whilst giving audio prompts. Consistent audio 
instructions were recommended to avoid misinterpretation by the patient and aid communication 
between the ABC operator and linac operator.  
 
Quality assurance of ABC 
Two ABC devices were used, one for CT and one for treatment. It is essential that breath hold 
volumes for predetermined thresh hold levels are consistent within and compared to each device. 
A calibration system was devised using a 3 litre volumetric syringe (Hans Rudolph Model 5530) 
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and in house developed ABC volume curve analysis software. The ABC turbine and valve were 
coupled directly to the syringe and the laptop computer connected directly to the ABC control unit. 
Repeated syringed ‘breath’ holds using a threshold of 1 litre were performed and the volume of 
the syringe plunger position was measured using a scaled ruler with 0.01 litre increments.   The 
software analyses  volume curves to give statistical data for each breath and generates a chart 
for analysis. The breath statistics produced are: the indicated air volume (Vr), the peak flow and 
the average of the flow while the flow was greater than one – half of the maximum (Fahm), and 
the start and stop times for each breath. For held breaths the additional statistics were: the 
threshold volume (Vt), the start and stop times of the hold and the flow averaged over the first 
100 ms of the hold period (Fh). This software was also used to analyse the patients breath holds 
during planning and treatment sessions.  
To quantify the effect of varying flow rates on actual lung volume at breath hold the volumes 
recorded by the ABC at the repeat planning scans were compared to the volumes measured by 
outlining the lungs on the CT scans in the first 13 patients. 
We also compared the variation in tidal volume prior to commencement of breath holding with the 
variation in breath hold volumes. The tidal volume was assessed by measuring the difference 
between the ABC device recorded values at maximum inspiration and maximum exhalation. The 
volumes were only recorded in the time period between the first and second breath-holds. Within 
this period any volumes recorded close to the breath-holds were not included. The exclusion was 
due to visual inspections of the breathing traces revealing that many patients altered their 
breathing pattern to compensate for previous, or anticipate upcoming, breath-holds. It was a 
possibility that even a single breath-hold might significantly alter the tidal volumes. To guard 
against this possibility some patients had the tidal volumes before treatment assessed. These pre 
breath hold volumes were compared to those measured in-between the first and second breath 
hold. This was only possible in cases when the ABC device had been on for a significant time 
before treatment and the patient had been at rest.  
This study aims to test the tolerability of the ABC in patients receiving radical radiotherapy for 
NSCLC. In order for ABC to be used routinely in clinical practice patients must be able to hold 
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their breath for at least 15 secs, about 7 times for each treatment. In our earlier study 80% of 
patients were able to achieve this. If the success rate is <50% then the device is unlikely to be 
introduced into clinical practice.  In order to detect this level of success we aimed to recruit 18 
patients into this study. If 13 or more patients were able to tolerate the  ABC then we proposed to 
introduce this into clinical practice  ( α1-sided =5%;power=80%)[20] 
Results 
 
Feasibility 
17 patients completed 32 fractions of radiotherapy. 1 patient (patient 13) requested to be treated 
without the device after 2 weeks of treatment The mean (SD) patient training time from entering 
the room to determining maximum breath hold time  was 13.8(4.8) mins. 
All patients tolerated a maximum breath hold time of >15 seconds; median 20 secs (range 15 -
25secs). There was no relationship with the maximum breath hold time and age, FEV1 or 
performance status (Figure 2). 
The mean (SD) threshold level was 1.33(0.38) litres held at a mean (SD) of 69 (13)% of the MIV. 
The mean (SD) breath hold volumes per patient as recorded by ABC ranged between 1.10l and 
2.6l (0.03-0.23l) (Figure 3).  Since the beam wedge filter takes ~ 6secs to move into place the 
breath holds during treatment were often split to correspond with any wedged/unwedged changes 
in the field. This resulted in a mean (SD) breath hold time required per patient of between 10 -14 
(2-7) secs with a mean of 6 -13 breath holds per treatment session. The maximum breath hold 
time was determined by the patient and was generally <25 secs. 
 
CT planning 
All planning scans were acquired in a single breath hold. Although the increased pitch reduced 
resolution, the breath hold increased resolution by eliminating blurring due to breathing and 
resulted in a good quality CT scan (Figure 4a and 4b).    
 
Treatment 
The mean (SD) treatment time (patient on – off the bed) was 15.8(5.8) mins.  
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Questionnaires of 15 patients were collected. No patient found the ABC very uncomfortable. 2 
patients found the device ‘Quite a bit uncomfortable’ at CT planning but this decreased to ‘A little’ 
after week 1. The level of discomfort increased during treatment in only one patient and this was 
due to the patient having a cold. Patients recorded  problems with the nose piece (2 patients), dry 
mouth (2 patients) and coughing (1 patient). 6 patients made positive comments regarding how 
staff encouraged and helped them relax.  
 
Set-up accuracy 
Using the NAL protocol the ∑ was <2 mm in the right-left (RL) and the anterior-posterior (AP) 
direction (Table 1). A ∑ of 2.4 mm remained in the superior-inferior direction which was also the 
direction where the largest random error was determined.  
 
Quality Assurance 
Calibration of devices showed the breath hold volume was related to speed of flow at threshold 
level (Figure 5). This is due to the reaction time of the ABC devices which was recorded as 124 
msec and 106 msec of CT and treatment ABC respectively. Patients mean (SD) flow rates at 
breath hold ranged between 0.67 – 2.04 l/s (0.17-0.76).  
To quantify the effect of varying flow rates on the lung volume at breath hold the lung volumes on 
the 10 patients who had 3 planning CT scans were outlined and compared to the volumes 
recorded by the ABC. The repeat CT scans during treatment were not used because the 
treatment may affect the lung volume. The mean (SD) ABC-held lung volume on CT scans 
ranged between 3953-7326cm3 (15-271cm3) per patient and the mean (SD) lung volumes 
recorded by the ABC were 1.18 - 2.57l (0.01 - 0.05l) per patient. The SD of individual patients 
ABC-held lung volume was  <4 % in 16 patients and 6.1 % in 1 patient.  
The pre breath hold values of tidal volume were found to be in agreement with the values 
recorded in-between the first and second breath holds in all of the cases measured.  In 15/18 
patients the SD of the tidal volume between the first and second breath hold was greater than the 
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SD of the breath holds. Values taken in-between subsequent breath-holds were found to 
increasingly deviate from the pre breath hold values.      
 
 
Discussion 
This is the first study focusing on the feasibility of the use of ABC during the complete course of 
radical radiotherapy for NSCLC.  Seventeen out of 18 patients completed a 6 ½ week radical 
course of radiotherapy using ABC. The mean breath hold time of 20 secs determined here was 
comparable with our previous study [15] and  studies where the feasibility of ABC  was evaluated 
but not combined with treatment [9,7,21]. However it was not necessary to continually use the 
maximum breath hold time during treatment, mean breath hold time during treatment was 10 -14 
secs. The acceptability rate with ABC is higher compared to studies using deep inspiration breath 
hold (dIBH). This may be because of differences in breath hold volumes. ABC uses 70%-80% of 
MIV whereas dIBH used 100% vital capacity which may cause fatigue when performing repeated 
breath holds [22].  We have since implemented ABC for all NSCLC patients receiving 
radiotherapy and recommend that the patient be able to hold their breath for a minimum of 15 
seconds. The addition of concomitant chemotherapy may impact the feasibility. However 13/18 
patients in this study received chemotherapy prior to radiotherapy and the patient who did not 
complete the study had not received chemotherapy. Exhale has been shown to hold the tumour 
in a more reproducible position than inhale [23]. The ABC uses exhale as its reference volume so 
the mid deep inspiration (mDIBH) breath hold is relative to the exhale volume. The additional 
advantage of treating during inhalation is that the V20 and the mean lung dose decreases with an 
increase in lung volume there is potential for dose escalation [24]. We have demonstrated that 
using ABC the dose could theoretically be escalated from 64Gy to a mean of 73.7 +/- 6.5Gy 
resulting in a statistically significant increase in tumour control probability from 0.15 +/- 0.01 to 
0.29 +/- 0.11 [25].  
In earlier reported studies it was not possible to complete the planning scan in one breath hold 
[8,26,27,9,7]. However modern multislice CT scanners enable a fast protocol to cover the entire 
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thorax. Although there is a risk of losing resolution, a fast scan enables a single breath hold ABC 
scan which reduces blurring caused by breathing. 
Coaching for breath hold is essential for the success of the procedure. During gating a 
combination of audio and visual aids improve the reproducibility of breathing cycles; audio aid 
improves frequency and visual aid the amplitude of each breath [28]. With ABC we found that 
audio coaching was adequate. It has been suggested that patients need to be coached to breathe 
evenly and consistently to ensure a consistent held volume and avoid changes in the tumour 
position with each breath hold, particularly because the ABC resets expiration to zero [8].  
However comfortable inspiration may be difficult to reproduce. When we compared the variation 
in tidal volume (‘uncoached’) with the variation in ABC-held volumes, 15/18 patients had more 
reproducible ABC-held volumes.  
The delay between the ABC activation and the balloon valve closing causes a variation in held 
volume, depending on the flow rate when the threshold volume is reached (Figure 5). Any 
difference in volume held may result in a variation of tumour position. With a flow rate of 2 l/s 
there was a 300ml overshoot for 1.8l inspired volume but this was reduced for a rate of 1 l/s [29]. 
In our patients the mean flow rate at the threshold level was 0.67 - 2.04l/s and mean (SD) breath 
hold was 1.10 - 2.6l (0.03 - 0.23l). The important factor is whether the patient’s flow rate and 
subsequent breath hold are consistent. To investigate the relevance of the varaition in ABC 
recorded volumes we used the 3 repeat planning CT scans acquired in the first 12 patients.  The 
overshoot of the threshold volume on the ABC was 80 – 400ml (Figure 3)  but the SD of the lung 
volume measured on the CT was < 6% of the total lung volume. We also determined the intra 
fraction reproducibility of the tumour position during these breath holds to be  < 2mm,  [Brock J , 
unpublished] which corresponds with the intrafraction reproducibility of an earlier version of the 
ABC device in our  previous study [15]. This suggests that although there is an overshoot beyond  
the threshold this is consistent for a given patient, and the variation in held lung volume of < 6% 
of the mean lung volume does not result in clinically significant changes in tumour position. 
However this is patient dependant and needs to be investigated further in a larger group of 
patients. 
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For example, patient number 8 had the largest SD (0.23l) of breath hold volumes and appeared 
to perform a large exhale before inhalation which may have contributed to the variation. However 
closer inspection revealed that the SD was explained by extremely variable initial breath holds in 
3 fractions. This may have been due to the patient or equipment problems and was resolved 
before treatment commenced. When these initial breath holds were removed the SD was 0.08 l 
illustrating the consistency of the unusual breath hold pattern i.e performing large exhales prior to 
breath hold.   
Reproducibility of breath hold and tumour position may also be related to lung volume and tumour 
location for example lower lobe tumours may be more sensitive to lung volume changes.  
Staff training is important because confident staff will help the patient to relax. 6 patients made 
positive comments regarding the instructions given by the radiographers. The importance of clear  
communication has been emphasised in earlier studies  where poor communication was cited as 
a reason for patients not tolerating ABC [14,30]. 
EPI images and bony anatomy were used to evaluate set up displacements and although the ∑ 
and σ errors found here agreed with other published reports EPI has been shown to be less 
accurate than 3D, kilo-voltage imaging, cone beam CT (CBCT) due to the poor image quality of 
EPI in the thorax region [31]. Using the diaphragm as a surrogate of tumour position may seem 
logical, particularly since the patient is in breath hold.  However this does not provide an accurate 
surrogate [32]. The 2 mins required to acquire a CBCT image is too long for a single breath hold 
and currently it is not possible to interrupt the CBCT acquisition. However we have since acquired 
CBCTs with the patient performing repeated breath holds with maximum breath hold time. The 
majority of the projections are therefore acquired with the patient in breath hold and the 
reconstructed scan has been suitable for matching to the planning CT scan.    
 
 
Conclusions 
The use of ABC in patients receiving radical radiotherapy for NSCLC is feasible.  Patients ability 
to breath hold was not related to age, performance status or FEV1. A minimum tolerated breath 
hold time of 15 secs is recommended prior to commencing treatment. The breath hold volumes 
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were reproducible during treatment and also between two ABC devices.  ABC allows the potential 
for dose escalation and possibly improved tumour control. The development of equipment and 
software to allow gating of the ABC with the linac and the acquisition of CBCT with breath hold  
would improve the treatment delivery and verification. 
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Figure 1. Schematic diagram showing breathing cycle, when to prompt the patient to take a deep 
breath and the breath hold  
Figure 2. Age, breath hold time and performance status (PS) of patients treated with ABC 
 
Figure 3. Mean and standard deviation (SD) of breath hold volumes at treatment recorded by 
ABC compared to the predetermined threshold volume  
 
Figure 4a. CT scan acquired with patient in Free Breathing (FB)  
 
Figure 4b. CT scan acquired with patient using Active Breathing Co ordinator (ABC) 
  
Figure 5. Flow at hold v volume held measured using 3l volumetric syringe  
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Figure 3. 
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Table 1 Patient and tumour characteristics  
Age  PS Stage 
Tumour 
position FEV1 Chemotherapy 
GTV 
(cm3) 
Max 
breath 
hold 
time 
(secs) 
65 1 IB RMZ - Y 32.9 20 
85 1 IIIB RLL 1.36 Y 18.6 20 
76 1 IIIB LUL 1.67 Y 41 15 
63 1 IIIB RMZ 1.5 Y 21.5 25 
74 1 IIIA LLL - Y 89.6 25 
62 0 111B Central  - Y 85.2 20 
63 1 IIIB Lt Hilar - Y 76.81 20 
59 1 IIIB LUL 2.8 Y 20 25 
44 0 111B RUL 3.03 Y 47.9 20 
79 0 IB/IIA RML 1.65 N 22.4 20 
67 0 IIIA LLL - Y 6.4 20 
60 1 IIIB LUL 1.82 Y 45.9 20 
79 2 IB LLL - N 24.3 15 
59 1 IB RUL 1.7 Y 35.9 15 
76 0 IIB RUL - N 43.3 15 
77 0 IB RLL - N 53.87 20 
61 0 IIIA RUL 1.88 N 55.28 20 
79 1 III A RUL - Y 96.28 25 
22 
Table2.Set-up errors calculated without (i.e aligning to skin marks only) and with the no action 
level protocol applied 
 
 
 
Set up protocol Right-left (mm) Superior-Inferior 
(mm) 
Anterior-posterior 
(mm) 
∑  Skin marks 
 
2.9 3.9 1.9 
σ Skin marks 
 
3 4 2.2 
∑ No action level protocol 
 
1.9 2.4 1.4 
σ No action level protocol  
 
3 3.7 2.1 
 
∑ - Systematic error 
σ - Random error 
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